Felipe Marcondes de Oliveira Coelho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Felipe Marcondes de Oliveira Coelho has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Thaís Paiva Moraes
Redimama-Redimasto Breast Unit, Belo Horizonte, Brazil
3 shared publications - Aleida Nazareth Soares
Santa Casa Faculty of Health Sciences, Belo Horizonte, Brazil
2 shared publications - Amanda Cristina Braga de Oliveira
Redimama-Redimasto Breast Unit, Belo Horizonte, Brazil
2 shared publications - Ana Carolina Guglielmelli Mendonça
Redimama-Redimasto Breast Unit, Belo Horizonte, Brazil
2 shared publications - André Mattar
Women Hospital, São Paulo, Brazil
2 shared publications - Annamaria Massahud Rodrigues dos Santos
Social Security Institute for Public Servants of Minas Gerais, Belo Horizonte, Brazil
2 shared publications
Latest Publications
- 28 September 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 11000-11001
ASO Visual Abstract: Cavity Margins Sample Shaving Evaluation as Part of Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Breast Cancer Excision
- 28 September 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 11000-11001
ASO Visual Abstract: Cavity Margins Sample Shaving Evaluation as Part of Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Breast Cancer Excision
- Open Access
- 28 August 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10918-10929
Cavity Margins Sample Shaving as Part of Extended Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Percutaneous Breast Cancer Excision
Background: Excision of small breast cancers has been reported by vacuum-assisted biopsy (VAB). Nevertheless, patients are submitted to surgery, because there is no way to predict excision. The purpose of this study was to evaluate extended vacuum-assisted biopsy (EVAB) associated with cavity margins sample shaving (CMSH) to predict breast cancer excision. Methods: This is a retrospective database analysis of 120 cancers [both invasive breast cancers (IC) and ductal carcinoma in situ (DCIS)] diagnosed by EVAB-CMSH submitted to surgery with histological data from EVAB-CMSH and surgery. The CMSH was evaluated as a diagnostic test for excision compared to surgery as gold standard. Factors associated with residual tumor, gross residual tumor (GRD) (> 3 mm), and false-negative CMSH after EVAB-CMSH were evaluated. Results: A total of 120 cases were analyzed. Media age was 57 (48.5–69); image tumor size ( T ) was 11 (8.6–15) mm; pathological tumor size (pT) was 6 (4–10) mm; most cases IC+DCIS 53 (44.2%), DCIS 46 (38.3%), and IC 15 (12.5%); 45 (37.5%) were excised by EVAB-CMSH. CMSH sensitivity 70.7%, specificity 66.7%, false-negative rate 18.33%, and accuracy 69.2%. In multivariate analysis, DCIS pT ( p = 0.003, odds ratio [OR] 1.46, 95% confidence interval [CI]) was associated with residual tumor; DCIS pT ( p = 0.001, OR 1.34, 95% CI) and the CMSH T ( p = 0.001, OR 1.67, 95% CI) with GRD; surgical specimen DCIS T ( p = 0.015, OR 1.12, 95% CI) with CMSH false negative. Conclusions: Cavity margins sample shaving is a potential approach to predict small breast cancer excision and should be added to vacuum-assisted excision in prospective trials. For DCIS, EVAB-CMSH should not be standard of care.
- 28 August 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10918-10929
Open AccessCavity Margins Sample Shaving as Part of Extended Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Percutaneous Breast Cancer Excision
Background: Excision of small breast cancers has been reported by vacuum-assisted biopsy (VAB). Nevertheless, patients are submitted to surgery, because there is no way to predict excision. The purpose of this study was to evaluate extended vacuum-assisted biopsy (EVAB) associated with cavity margins sample shaving (CMSH) to predict breast cancer excision. Methods: This is a retrospective database analysis of 120 cancers [both invasive breast cancers (IC) and ductal carcinoma in situ (DCIS)] diagnosed by EVAB-CMSH submitted to surgery with histological data from EVAB-CMSH and surgery. The CMSH was evaluated as a diagnostic test for excision compared to surgery as gold standard. Factors associated with residual tumor, gross residual tumor (GRD) (> 3 mm), and false-negative CMSH after EVAB-CMSH were evaluated. Results: A total of 120 cases were analyzed. Media age was 57 (48.5–69); image tumor size ( T ) was 11 (8.6–15) mm; pathological tumor size (pT) was 6 (4–10) mm; most cases IC+DCIS 53 (44.2%), DCIS 46 (38.3%), and IC 15 (12.5%); 45 (37.5%) were excised by EVAB-CMSH. CMSH sensitivity 70.7%, specificity 66.7%, false-negative rate 18.33%, and accuracy 69.2%. In multivariate analysis, DCIS pT ( p = 0.003, odds ratio [OR] 1.46, 95% confidence interval [CI]) was associated with residual tumor; DCIS pT ( p = 0.001, OR 1.34, 95% CI) and the CMSH T ( p = 0.001, OR 1.67, 95% CI) with GRD; surgical specimen DCIS T ( p = 0.015, OR 1.12, 95% CI) with CMSH false negative. Conclusions: Cavity margins sample shaving is a potential approach to predict small breast cancer excision and should be added to vacuum-assisted excision in prospective trials. For DCIS, EVAB-CMSH should not be standard of care.
- Open Access
Advances in breast imaging: a review on where we are and where we are going
Breast radiology has undergone significant advances in recent years, and, naturally, several possibilities open up for attending physicians. Concomitantly, it increases the responsibility to keep up to date and provide the best care for each patient. Aware of the complex implications that the implementation of some of the technological advances may bring, such as increased costs, limited availability of equipment, and a potential increase in examination time, the objective of this study is to carry out a narrative review and provide a collection of advances that, in our opinion, are already gaining ground and should be consolidated in clinical practice. We will discuss new breast imaging methods that can be used both for screening and for the diagnostic investigation of breast lesions and we will summarize the most relevant aspects of each of them, addressing the technique, applicability, positive aspects, and limitations of each modality in a standardized way.
Open AccessAdvances in breast imaging: a review on where we are and where we are going
Breast radiology has undergone significant advances in recent years, and, naturally, several possibilities open up for attending physicians. Concomitantly, it increases the responsibility to keep up to date and provide the best care for each patient. Aware of the complex implications that the implementation of some of the technological advances may bring, such as increased costs, limited availability of equipment, and a potential increase in examination time, the objective of this study is to carry out a narrative review and provide a collection of advances that, in our opinion, are already gaining ground and should be consolidated in clinical practice. We will discuss new breast imaging methods that can be used both for screening and for the diagnostic investigation of breast lesions and we will summarize the most relevant aspects of each of them, addressing the technique, applicability, positive aspects, and limitations of each modality in a standardized way.
Lifestyle and breast cancer: review article
The aim of this study was to improve our knowledge about carcinogenesis and lifestyle, given their impact on the occurrence of breast cancer, emphasizing the importance of lifestyle changes as a preventive factor in the development of the disease. We conducted a bibliographic review with the analysis of 31 articles in English and Portuguese. As a result, the articles selected for study showed that factors such as diet, alcohol intake, smoking, obesity, physical activity, occupational exposure, hormonal factors (hormone therapy, contraceptives) and reproductive factors (menarche, menopause, nulliparity, pregnancy, breastfeeding) have a protective or risk effect on breast cancer. We conclude that eating healthy, with fruits, vegetables and greens, practicing moderate physical activity, avoiding alcoholic beverages and breastfeeding exclusively reduce the risk of developing breast cancer by 28%. Therefore, it is necessary to make the public aware of these modifiable risk factors.
Lifestyle and breast cancer: review article
The aim of this study was to improve our knowledge about carcinogenesis and lifestyle, given their impact on the occurrence of breast cancer, emphasizing the importance of lifestyle changes as a preventive factor in the development of the disease. We conducted a bibliographic review with the analysis of 31 articles in English and Portuguese. As a result, the articles selected for study showed that factors such as diet, alcohol intake, smoking, obesity, physical activity, occupational exposure, hormonal factors (hormone therapy, contraceptives) and reproductive factors (menarche, menopause, nulliparity, pregnancy, breastfeeding) have a protective or risk effect on breast cancer. We conclude that eating healthy, with fruits, vegetables and greens, practicing moderate physical activity, avoiding alcoholic beverages and breastfeeding exclusively reduce the risk of developing breast cancer by 28%. Therefore, it is necessary to make the public aware of these modifiable risk factors.